✦ LIBER ✦

383. Can RECIST be considered a predictor of outcome in patients with liver metastases from colorectal cancer?

✍ Scribed by Ferro, A.; Pilati, P.; Nitti, D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

331. Neoadjuvant folfiri + bevacizumab i

✍ Izzo, F.; Palaia, R.; Albino, V.; Di Giacomo, R.; Amore, A.; Saponara, R.; Leong 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Clinical short-term results of radiofreq

✍ G. Basdanis; A. Michalopoulos; V. Papadopoulos; I. Tzeveleki; Ch. Efthimiadis; C 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 34 KB

Histopathologic evaluation of liver meta

✍ Loupakis, F; Schirripa, M; Caparello, C; Funel, N; Pollina, L; Vasile, E; Cremol 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 638 KB

Diagnostic performance of MDCT, PET/CT a

✍ V. O. Chan, J. P. Das, J. F. Gerstenmaier, J. Geoghegan, R. G. Gibney, C. D. Col 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 333 KB

A Phase I Trial of Isolated Hepatic Perf

✍ Magge, D.; Zureikat, A. H.; Bartlett, D. L.; Holtzman, M. P.; Choudry, H. A.; Be 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 458 KB

A prospective evaluation of treatment wi

✍ L Lim; P Gibbs; D Yip; JD Shapiro; R Dowling; D Smith; A Little; W Bailey; M Lie 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 362 KB